Skip to main navigation
Skip to search
Skip to main content
Sort by
Medicine and Dentistry
Adenoma
35%
All Cause Mortality
6%
Anastomosis Leakage
6%
Biological Marker
14%
Cancer
9%
Cancer Diagnosis
10%
Charlson Comorbidity Index
8%
Circulating Tumor DNA
13%
Cohort Analysis
29%
Colon
9%
Colon Carcinoma
9%
Colonoscopy
88%
Colorectal Cancer
40%
Colorectal Cancer Screening
97%
Colorectal Carcinoma
100%
Colorectal Surgery
6%
Colorectal Tumor
6%
Comorbidity
9%
COVID-19
6%
Cross Sectional Study
15%
Diseases
20%
Endoscope
6%
Endoscopic Surgery
6%
Endoscopy
18%
Fluid Balance
6%
Fluid Therapy
6%
Guaiacum
6%
Health Care Cost
7%
Hemicolectomy
6%
Hemoglobin Determination
6%
High Risk Population
10%
Intermediate Care
6%
Intestine Preparation
8%
Laparoscopic Surgery
15%
Malignant Neoplasm
27%
Morbidity
9%
Neoplasm
8%
Observational Study
15%
Occult Blood Test
70%
Oncologist
6%
Phlebothrombosis
6%
Polyp
7%
Precursor
10%
Prevalence
15%
Randomized Controlled Trial
6%
Recurrent Disease
8%
Screening Program
49%
Sensitivity and Specificity
14%
Stroke Volume
6%
Thromboprophylaxis
10%
Keyphrases
Adenoma
15%
Adenoma Detection Rate
9%
Blood Biomarkers
17%
Blood-based
13%
Body Composition
11%
Bowel Preparation
8%
Cancer-associated Proteins
8%
Cause of Death
9%
Circulating Tumor DNA (ctDNA)
13%
Clinical High Risk
6%
Colon
8%
Colonoscope
7%
Colonoscopy
68%
Colorectal Cancer
83%
Colorectal Cancer Incidence
10%
Colorectal Cancer Screening
99%
Colorectal Neoplasms
7%
COVID-19
8%
Denmark
48%
Early Detection
9%
European Guidelines
7%
Fecal Immunochemical Test
73%
GH Release
9%
Growth Factors
12%
Growth Hormone Release
13%
Hypoglycemia
6%
IGF-binding protein-3
7%
Insulin-like
16%
Laparoscopic Surgery
6%
Low-risk Adenomas
9%
National Cohort Study
35%
Obese Subjects
19%
Population Screening
9%
Population-based
10%
Post-colonoscopy
7%
Post-colonoscopy Colorectal Cancer
7%
Relative Risk
18%
Release Profile
7%
Risk Factors
8%
Screen-detected
32%
Screening for Colorectal Cancer
18%
Screening Population
9%
Screening Program
8%
Serum Biomarkers
8%
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
8%
Test Screening
17%
Test-based
28%
Thromboprophylaxis
6%
Triage
7%
Type 1 Diabetic Patient
13%
